Trial intelligence / Profile preview

Effects of THC on Fear Extinction in PTSD

NCT03008005Phase 4Completed

Sponsor
Wayne State University
Start
Jun 2017
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dronabinol in post-traumatic stress disorder (PTSD) (3 arms), sponsored by Wayne State University. Primary endpoints: Brain Measures (fMRI activation) at Day 21 and Expectancy Ratings at Day 21. Started Jun 2017; status: completed.

02

Drugs

dronabinol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT03008005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03008005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call